gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Glofitamab binds CD3 to activate and redirect T cells, which then kill CD20+ B cells via CTL-mediated perforin/granzyme apoptosis; CD3+ T cells themselves are not targeted for killing.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
T-cell surface antigen; part of TCR complex
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06090539
disease_id_num_tar_ref
4971
drug_id_num_tar_ref
13412